Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27266927 | 0.82 | CYP17A1 (0.33) | CYP19A1CYP3A4CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL27274400 | 0.78 | CYP51A1 (0.32) | CYP19A1CYP3A4CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL27325119 | 0.70 | LTA4H (0.31) | CYP19A1CYP3A4CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL7680971 | 0.64 | CYP3A4 (0.67) | CYP19A1CYP3A4CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL8737044 | 0.62 | CYP19A1 (0.59) | CYP19A1CYP3A4CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL11062159 | 0.62 | CYP3A4 (0.53) | CYP19A1CYP3A4CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL10501038 | 0.59 | CYP3A4 (0.39) | CYP19A1CYP3A4CYP17A1CYP11B1CYP11B2 | |
| Acetic Acid SCHEMBL28094255 | 0.58 | SMN1; SMN2 (0.55) | CYP19A1CYP3A4CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL477399 | 0.57 | SMN1; SMN2 (0.65) | CYP19A1CYP3A4CYP17A1CYP11B1CYP11B2 | |
| SCHEMBL9528623 | 0.57 | GAA (0.67) | CYP19A1CYP3A4CYP17A1CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1031264-C | Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones | MERRELL DOW PHARMA (US) | 1996-03-13 | — | — | CN | disclosed |
| CN-1019197-B | Preparation of 1-3-dihydro-4-pyridinoacyl-2H-imidazol-2-ones | MERRELL DOW PHARMACEVTICALS IN (US) | 1992-11-25 | — | — | CN | disclosed |
| CN-1057261-A | The preparation of 1-3-dihydro-4-pyridine acyl-2H-imidazole-2-ketone compound | MERRELL DOW PHARMACOUTICALS IN (US) | 1991-12-25 | — | — | CN | disclosed |
| CN-1055737-A | The preparation of 1-3-dihydro-4-pyridine acyl-2H-imidazole-2-ketone compound | MERRELL DOW PHARMA (US) | 1991-10-30 | — | — | CN | disclosed |
| CN-85106722-A | Preparation of 1, 3-dihydro-4-pyridinoacyl-2H-imidazol-2-ones | — | 1987-03-25 | — | — | CN | disclosed |